Literature DB >> 10674976

High-throughput class I HLA genotyping using fluorescence resonance energy transfer (FRET) probes and sequence-specific primer-polymerase chain reaction (SSP-PCR).

A R Gelsthorpe1, R S Wells, A P Lowe, S Tonks, J G Bodmer, W F Bodmer.   

Abstract

We have developed a semi-automated HLA class I typing system utilising TET/TAMRA-labelled fluorescence resonance energy transfer (FRET) hydrolysis probes. The results from 87 individuals are in full concordance with serology and conventional gel-based systems. This assay replaces labour-intensive conventional gel-based DNA typing and has a higher allelic resolution than serology. Our approach differs from previously published fluorogenic probe typing protocols in that it provides simultaneous typing of HLA-A, -B and -C loci to medium resolution. Furthermore, by using equipment that is not specific to FRET probe analysis our system has in-built expansion capacity to 384 reactions per plate, thus making it applicable to high-throughput population screening. Automation is achieved through the use of computer software which analyses direct input from the fluorescence reader, allowing high throughput with a low inherent error rate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10674976     DOI: 10.1034/j.1399-0039.1999.540611.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  2 in total

1.  Alkaline-mediated differential interaction (AMDI): a simple automatable single-nucleotide polymorphism assay.

Authors:  S Bartlett; J Straub; S Tonks; R S Wells; J G Bodmer; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

2.  Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations.

Authors:  Aubin J Nanfack; Lucy Agyingi; Jean Jacques N Noubiap; Johnson N Ngai; Vittorio Colizzi; Phillipe N Nyambi
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.